Are Wall Street Analysts Predicting Becton, Dickinson and Company Stock Will Climb or Sink?
Becton, Dickinson and Company (BDX) stock prices have been a topic of discussion among Wall Street analysts. While the company has underperformed the broader market over the past year, it has shown surprising strength in 2026, outpacing the S&P 500 Index. In the first half of 2026, BDX's stock rose by 20.2%, compared to the SPX's 13.7% increase.
Analysts are generally optimistic about BDX's future, with the consensus rating being "Moderate Buy" based on 16 analysts covering the stock. Joanne Wuensch from Citigroup reiterated a "Buy" rating for BDX, predicting a potential upside of 13.4% from the current level. Despite recent headwinds, including sluggish revenue growth and challenges in international markets, BDX's performance in its core segments, such as drug delivery devices, and its long-standing status as a reliable Dividend King have helped restore investor confidence.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.